A new study suggests the shingles vaccine could reduce dementia risk and may even slow progression in those already diagnosed, offering hope for millions.
The UK’s Horizon trial will test a vaccine against the Epstein-Barr virus (EBV), linked to multiple sclerosis, aiming to train the immune system and explore a potential new treatment for MS.
Cancer Research UK is backing a £2.06 million, first-in-human trial of LungVax, a preventative vaccine designed to prime the immune system against early lung cancer.
New UKHSA and NHS England data reveal 18.6% of children have not received their pre-school booster vaccine, a vital vaccine for protecting against serious illnesses.
The University of Oxford has launched a £118M AI vaccine research programme, CoI-AI, with the Ellison Institute, aiming to combat antibiotic resistance through human challenge trials.
Murdoch Children’s Research Institute launches an international trial of a 21-valent pneumococcal vaccine to protect babies against pneumonia, meningitis, and sepsis.
The NHS is starting the world’s first vaccine programme to prevent gonorrhoea, using the 4CMenB meningitis vaccine in high‑risk groups from August 2025.
Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
The NHS will offer a long-acting antibody injection to protect thousands of premature and vulnerable babies from respiratory syncytial virus (RSV) starting this autumn.
